Clinical trials - Press Releases

Date	Title	Company
30-Jun-2023	Teva’s 3rd interim analysis of PEARL real-world study on AJOVY® (fremanezumab) reveals sustained long-term effectiveness in reducing frequency, duration and severity of attacks in patients with chronic and episodic migraine	teva
29-Jun-2023	IgniteData and Leading New York City Cancer Center Collaborate to Solve the Clinical Trial Data Transfer Challenge	IgniteData
28-Jun-2023	Sotyktu™▼ (deucravacitinib) recommended for use on the NHS in England as a first-in-class treatment option for moderate to severe plaque psoriasis in adults	Bristol Myers Squibb (BMS)
28-Jun-2023	Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are Active	DopaVision
27-Jun-2023	Cyntegrity’s MyRBQM Portal, an AI-Supported Clinical Trial Risk Management Solution, is Now Available in the Microsoft Azure Marketplace	Cyntegrity
27-Jun-2023	GPCR passes Technology Evaluation process for listing on KOSDAQ	GPCR Therapeutics
27-Jun-2023	Sobi completes acquisition of CTI BioPharma Corp.	CTI BioPharma Corp.
27-Jun-2023	Commercial trial to treat major depressive disorder with psychedelic drugs given green light by MHRA	Clerkenwell Health
27-Jun-2023	DIPHARMA AND LOGIXX PHARMA ANNOUNCE GRANTING OF MARKETING AUTHORISATION APPROVAL FOR GENERIC SAPROPTERIN IN UNITED KINGDOM	Dipharma SA (“Dipharma”) and LogixX Pharma (“LogixX”)
27-Jun-2023	Taking higher-than-recommended doses of vitamin D for five years reduced the risk of atrial fibrillation	University of Eastern Finland
27-Jun-2023	Shareholders Approve all Board Proposals at Today’s Annual General Meeting	Santhera Pharmaceuticals
27-Jun-2023	Researchers highlight flaws in COVID-19 weather studies and call for improved publishing practices	The University of Manchester
27-Jun-2023	Immodulon Further Strengthens Leadership Team with the Appointments of Richard Couch as Chief Technology Officer and Owen Vaughan as Chief Regulatory Officer	Immodulon Therapeutics Ltd
27-Jun-2023	Astraveus raises €16.5 Million Series Seed round to advance the development of its automated, microfluidic Cell and Gene Therapy manufacturing platform	Astraveus SAS
27-Jun-2023	Cresset Creates New Vice President Role to Lead their Discovery CRO Business	Cresset
27-Jun-2023	Bloomsbury Genetic Therapies Completes Successful Scientific Advice Meeting with the MHRA regarding its BGT-INAD Program	Bloomsbury Genetic Therapies Limited
27-Jun-2023	New report from The King’s Fund shows the UK underperforming on treatable health conditions, says the ABPI	ABPI
27-Jun-2023	Researchers reveal mechanism of protection against breast and ovarian cancer	Francis Crick Institute
27-Jun-2023	Fewer than 1% of Type 2 Diabetes patients participate in clinical trials - despite more than 1 in 10 of US population living with the condition	Lindus Health
22-Jun-2023	Hemophilia Federation of America Launches Clinical Trial Finder Powered by Citeline Connect	Citeline